Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TRP | ENB |
|---|---|---|
| Price | $59.40 | $47.38 |
| Change today | ▼ 1.33% | ▼ 0.99% |
| Market cap | $61.88B | $105.59B |
| Return, 3 months | -12.8% | -11.9% |
| Return, year to date | +12.2% | +7.3% |
| Return, 1 year | +20.6% | +6.2% |
| P/E (TTM) | 25.1 | 25.7 |
| P/B | 3.4 | 2.5 |
| P/E percentile vs own 5y | 61st | 75th |
| Dividend yield | 4.10% | 5.69% |
| Revenue growth (YoY, latest qtr) | +5.7% | +97.1% |
| Net profit growth (YoY) | +17.8% | -32.4% |
| Gross margin | 50.5% | 25.7% |
| Operating margin | 45.0% | 13.6% |
| Net margin | 22.1% | 6.8% |
| Return on equity | 13.8% | 9.7% |
| Analyst target vs. price | +24.6% | +21.7% |
| Analyst buy share | 77% | 57% |
| RSI (14) | 40 | 38 |
| 30-day volatility | 18.9% | 19.0% |
| Max drawdown, 1 year | -15.3% | -15.4% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.